Literature DB >> 8967788

Lithium and psoriasis: cytokine modulation of cultured lymphocytes and psoriatic keratinocytes by lithium.

H M Ockenfels1, S N Wagner, C Keim-Maas, R Funk, G Nussbaum, M Goos.   

Abstract

The predominant cutaneous side effect of lithium is the exacerbation or aggravation of psoriasis, but the pathogenesis is still unclear. The hyperproliferation of keratinocytes and a dense lesional infiltrate of mononuclear cells are the hallmarks of psoriatic skin lesions. Interactions between keratinocytes and T cells are thought to be one reason for an increased secretion of proinflammatory cytokines and growth factors. To investigate whether lithium influences cytokines of the "psoriatic cytokine network', we established a coculture model with keratinocytes from psoriatic patients and from healthy controls cultured with HUT 78 lymphocytes and measured the cytokine levels of Il-2, Il-6, Il-8, IFN gamma and TGF alpha in the culture supernatants after treatment with lithium. Il-6 levels were slightly elevated in the supernatants obtained from psoriatic and control keratinocyte cultures after lithium treatment, but IFN gamma and Il-2 levels were elevated only in the lithium-treated cocultures with psoriatic keratinocytes. In contrast, these two cytokines were not affected by lithium in HUT 78 monocultures or in cocultures with normal epidermal cells. We also found slightly elevated TGF alpha levels in lithium-treated psoriatic cocultures but not in control cultures. We therefore demonstrated that lithium influences the cell communication of psoriatic keratinocytes with HUT 78 lymphocytes by triggering the secretion of TGF alpha, Il-2 and, massively, IFN gamma. It seems possible that lithium also influences similar parts of the psoriatic cytokine network in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8967788     DOI: 10.1007/bf02505220

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  35 in total

1.  T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis.

Authors:  E Y Chang; C Hammerberg; G Fisher; O Baadsgaard; C N Ellis; J J Voorhees; K D Cooper
Journal:  Arch Dermatol       Date:  1992-11

Review 2.  The role of epidermal cytokines in inflammatory skin diseases.

Authors:  D N Sauder
Journal:  J Invest Dermatol       Date:  1990-11       Impact factor: 8.551

3.  Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis.

Authors:  H S Anttila; S Reitamo; P Erkko; M Ceska; B Moser; M Baggiolini
Journal:  J Invest Dermatol       Date:  1992-01       Impact factor: 8.551

4.  Antiproliferative effects of recombinant alpha- and gamma-interferons on cultured human keratinocytes.

Authors:  B J Nickoloff; T Y Basham; T C Merigan; V B Morhenn
Journal:  Lab Invest       Date:  1984-12       Impact factor: 5.662

5.  [Cutaneous lesions due to lithium therapy (author's transl)].

Authors:  D Lambert; F Beer; R Gisselman; D Bouilly; J L Chapuis
Journal:  Ann Dermatol Venereol       Date:  1982       Impact factor: 0.777

6.  Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ.

Authors:  R Gillitzer; R Berger; V Mielke; C Müller; K Wolff; G Stingl
Journal:  J Invest Dermatol       Date:  1991-07       Impact factor: 8.551

Review 7.  Cytokine modulation of keratinocyte cytokines.

Authors:  J Ansel; P Perry; J Brown; D Damm; T Phan; C Hart; T Luger; S Hefeneider
Journal:  J Invest Dermatol       Date:  1990-06       Impact factor: 8.551

8.  Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin.

Authors:  M Sticherling; E Bornscheuer; J M Schröder; E Christophers
Journal:  J Invest Dermatol       Date:  1991-01       Impact factor: 8.551

9.  The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response.

Authors:  K Uyemura; M Yamamura; D F Fivenson; R L Modlin; B J Nickoloff
Journal:  J Invest Dermatol       Date:  1993-11       Impact factor: 8.551

10.  Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis.

Authors:  T Gomi; T Shiohara; T Munakata; K Imanishi; M Nagashima
Journal:  Arch Dermatol       Date:  1991-06
View more
  4 in total

1.  IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.

Authors:  K Asadullah; W Sterry; K Stephanek; D Jasulaitis; M Leupold; H Audring; H D Volk; W D Döcke
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

2.  Lithium and psoriasis: what primary care and family physicians should know.

Authors:  Mohammad Jafferany
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

3.  [Trigger factors for psoriasis].

Authors:  H M Ockenfels
Journal:  Hautarzt       Date:  2003-02-21       Impact factor: 0.751

4.  Psychodermatology: a guide to understanding common psychocutaneous disorders.

Authors:  Mohammad Jafferany
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.